Action OBI ONDINE BIOMEDICAL INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Ondine Biomedical Inc.

Actions

OBI

CA68234M2058

Marché Fermé - London S.E.
Autres places de cotation
 17:35:29 26/06/2024 		Varia. 5j. Varia. 1 janv.
8,25 GBX 0,00 % Graphique intraday de Ondine Biomedical Inc. +10,00 % -5,71 %
21/06 Les actions baissent en raison du ralentissement de la croissance du secteur des services AN
21/06 Ondine Biomedical célèbre la disponibilité de Steriwave dans la chaîne d'approvisionnement du NHS AN

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Ondine Biomedical - Corporate and Trading Update
AQ
Ondine Biomedical achieves milestone with NHS trust's adoption of Steriwave
AQ
Ondine Biomedical Inc. - First commercial adoption of Steriwave by the NHS
AQ
Ondine Biomedical - Appointment of new Chief Financial Officer
AQ
Ondine Biomedical Inc. - Photodisinfection recommended as Standard of Care
AQ
Ondine Biomedical’s nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMR
BU
Ondine Biomedical̢۪s Steriwave platform seeing strong adoption
AQ
Ondine Biomedical̢۪s Steriwave nasal photodisinfection platform now used across Canada
AQ
Ondine Biomedical shares potential impact of photodisinfection study on public health and safety
AQ
Ondine Biomedical reports photodisinfection is highly effective against key food-borne pathogens
BU
Ondine Biomedical shares Ottawa Hospital study on Steriwave nasal photodisinfection helping patients
AQ
Ondine Biomedical Inc. - Ottawa hospital presents Steriwave study results
AQ
Ondine Biomedical’s Nasal Photodisinfection Reduces Hospital Length of Stay, Readmissions and Antibiotic Use in Substantial Study at Major Ottawa Hospital
BU
Ondine's APDT reduces SARS-CoV-2 infectivity
AQ
Ondine’s nasal photodisinfection therapy (APDT) improves short-term and long-term immune response while significantly reducing SARS-CoV-2 infectivity
BU
Photodisinfection Found to Eradicate Biofilms Associated with Periprosthetic Joint Infections
AQ
Food Processing Plant Sees Huge Reduction in Employee COVID-19 Rates After Using Ondine Biomedical’s Nasal Photodisinfection
BU
Ondine Biomedical reports successful topline data from Phase 2 nasal photodisinfection trial
AQ
Nature publication reports that Ondine's nasal antimicrobial photodynamic disinfection therapy suppresses SARS-CoV-2 in COVID-19 patients
AQ
Ondine Biomedical completes patient recruitment for US Phase II nasal photodisinfection trial
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action OBI
  4. Actualités Ondine Biomedical Inc.
  5. Communiqués